These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 23928230)

  • 41. Toxic epidermal necrolysis with prominent facial pustules: a case with reactivation of human herpesvirus 7.
    Honma M; Tobisawa S; Iinuma S; Shibuya T; Komatsu S; Takahashi I; Ishida-Yamamoto A; Iizuka H
    Dermatology; 2010; 221(4):306-8. PubMed ID: 20861604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studying the changes of the related serum complement immune indexes in patients with occupational medicamentosa-like dermatitis induced by trichloroethylene and workers occupationally exposed to trichloroethylene].
    Zhao N; Wang HL; Yue F; Zeng ZM; Li HL; Huang YS; Chen RT
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Apr; 30(4):284-8. PubMed ID: 22804938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
    Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
    Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome.
    Ishida T; Kano Y; Mizukawa Y; Shiohara T
    Allergy; 2014 Jun; 69(6):798-805. PubMed ID: 24749495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
    Avancini J; Maragno L; Santi CG; Criado PR
    Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
    Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
    Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL
    Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of drug-induced hypersensitivity syndrome-like symptoms following HHV-6 encephalopathy.
    Saida S; Yoshida A; Tanaka R; Abe J; Hamahata K; Okumura M; Momoi T
    Allergol Int; 2010 Mar; 59(1):83-6. PubMed ID: 19946201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
    Hama N; Abe R; Gibson A; Phillips EJ
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.
    Simpson S; Taylor B; Burrows J; Burrows S; Dwyer DE; Taylor J; Ponsonby AL; Blizzard L; Dwyer T; Pittas F; van der Mei I
    Acta Neurol Scand; 2014 Nov; 130(5):328-37. PubMed ID: 24893674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased ratio of FoxP3+ regulatory T cells/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms.
    Morito H; Ogawa K; Fukumoto T; Kobayashi N; Morii T; Kasai T; Nonomura A; Kishimoto T; Asada H
    Clin Exp Dermatol; 2014 Apr; 39(3):284-91. PubMed ID: 24635062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation.
    Neuman MG; McKinney KK; Nanau RM; Kong V; Malkiewicz I; Mazulli T; Moussa G; Cohen LB
    Transl Res; 2013 May; 161(5):430-40. PubMed ID: 23333110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
    Kano Y; Shiohara T
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity.
    Hanafusa T; Azukizawa H; Matsumura S; Katayama I
    J Dermatol Sci; 2012 Mar; 65(3):213-9. PubMed ID: 22226608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome.
    Nakamura-Nishimura Y; Miyagawa F; Miyashita K; Ommori R; Azukizawa H; Asada H
    Br J Dermatol; 2018 Jun; 178(6):1430-1432. PubMed ID: 29150836
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunopathogenic Insights on Preferential Human Herpesvirus-6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms: A Scoping Review.
    Zhu H; Ren V
    J Cutan Med Surg; 2023; 27(4):388-398. PubMed ID: 37231539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses.
    Mitani N; Aihara M; Yamakawa Y; Yamada M; Itoh N; Mizuki N; Ikezawa Z
    J Med Virol; 2005 Mar; 75(3):430-4. PubMed ID: 15648066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
    Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
    Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F; Asada H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of interleukin-7 and interleukin-15 on the production of Th1 and Th2 cytokines by peripheral blood mononuclear cells from patients with tuberculosis].
    Yang XM; Dong DQ; Li C; Yang YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):403-6. PubMed ID: 17045026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.